Aligos Therapeutics Inc. (5WK0)
Market Open
28 Jul, 07:31
XDUS 
€
3. 52
-0.02
-0.565%
€
- Market Cap
- P/E Ratio
- Div Yield
650 Volume
-10.36 Eps
€ 3.54
Previous Close Want to track 5WK0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aligos Therapeutics Inc. (5WK0) Statistics
Valuation metrics
Market Cap -
Enterprise value -13.05M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.88
Enterprise Value/Revenue -5.97
Enterprise Value/EBITDA 0.09
Overview
Shares outstanding 6.18M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 13
Average volume (90 days) 4
Price summary
52-Week low 3.52
52-Week high 11.3
Beta -
50-Day moving average 5.88
200-Day moving average 7.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 19 Aug 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -40.25%
Operational effectiveness
Return on assets -0.27%
Return on equity -0.45%
Income Statement
Revenue (ttm) 2.19M
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -0.77%
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -24.19M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -0.73%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 5.25M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.9%
Book value per share (mrq) 5.16
Cash Flow
Cash flow statement -18.1M
Levered free cash flow (LFCF) -24.19M
